In addition, a study conducted by Deng et al. also found that RT alone cannot produce sustained anti-tumor immune effects, but a combination with PD-1/PD-L1 inhibitors can induce an increase in memory CD8 + T cells, resulting in long-lasting immune memory effects [23]. Here, PDCD1 is linked to neoplasm.